Cargando…
Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era
In the past decade, studies of innate immune activity against HIV-1 and other retroviruses have revealed a powerful array of host factors that can attack the virus at various stages of its life cycle in human and primate cells, raising the prospect that these antiviral factors could be manipulated i...
Autores principales: | Weatherley, Daryl Anne Victoria, Boswell, Michael Terence, Rowland-Jones, Sarah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702620/ https://www.ncbi.nlm.nih.gov/pubmed/29213273 http://dx.doi.org/10.3389/fimmu.2017.01616 |
Ejemplares similares
-
A CRISPR-Cas Cure for HIV/AIDS
por: Hussein, Mouraya, et al.
Publicado: (2023) -
Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
por: Zhang, Shuzhong, et al.
Publicado: (2020) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
por: Huang, Rih-Sheng, et al.
Publicado: (2020) -
Comprehensive CRISPR-Cas9 screen identifies factors which are important for plasmablast development
por: Pinter, Theresa, et al.
Publicado: (2022)